Skip to main content

Table 6 Distributions of TDLNs, PDLNs, and NDLNs and the positive rate for N(+) CRC patients, N(+) CRC patients with ≤ 21 TDLNs, or N(+) CRC patients with > 21 TDLNs according to the pathological N status

From: A reappraisal of lymph node dissection in colorectal cancer during primary surgical resection

Part I

Nodal positive (n = 42)

N1 (n = 17)

N2 (n = 25)

p value*

No. of TDLNs (mean ± SD)

21.2 ± 12.0

18.3 ± 10.9

23.2 ± 12.6

0.199

No. of PDLNs (mean ± SD)

6.2 ± 5.5

1.6 ± 0.7

9.3 ± 5.2

< 0.001

Positive rate (mean ± SD, %)

31.5 ± 23.3

12.8 ± 11.9

44.1 ± 20.5

< 0.001

No. NDLNs (mean ± SD)

15.0 ± 10.6

16.7 ± 10.8

13.9 ± 10.5

0.409

Part II

No. of PDLNs (mean ± SD)

 
 

Nodal positive (n = 42)

N1 (n = 17)

N2 (n = 25)

 

No. of TDLNs 21 (n=25, N1/N2, 12/13)

3.4 ± 3.8

1.6 ± 0.7

6.9 ± 3.6

 

No. of TDLNs > 21 (n=17, N1/N2, 5/12)

8.9 ± 6.6

1.6 ± 0.9

11.9 ± 5.4

 

p value**

0.007

0.907

0.011

 
  1. TDLNs total dissected lymph nodes, PDLNs positive dissected lymph nodes, NDLNs negative dissected lymph nodes, Positive rate No. PDLNs/No. TDLNs, %, SD standard deviation
  2. *Compared between N1 and N2 status, Student’s t test/Mann–Whitey U test
  3. **Compared between TDLN≤21 and TDLN>21, Student’s t test/Mann–Whitey U test